Commentary: Re-recurrence after surgical management of recurrent thyroid cancer

In this issue of Surgery, Xu et  al1 from China offered an interesting discussion of the management and prognostic implications of recurrent/persistent thyroid cancer, including an evaluation of the risk stratification guidelines published by the American Thyroid Association (ATA) in 2015.2 The ATA recommends using several periop erative clinicopathological features available at the time of initial therapy to categorize the risk of recurrence into low, intermediate, and high groups, which we had previously referred to as good, bad, and ugly.
Source: Surgery - Category: Surgery Authors: Source Type: research